Oct 28, 5:17 PM ET
Albany International reported third-quarter 2026 net revenue of $349.5 million, up 34% from $261.4 million a year earlier, and net income attributable to the company of $41.7 million, or $1.46 per diluted share, compared with a net loss of $97.8 million in the prior-year quarter. The company also issued an outlook for the fourth quarter of 2026 with consolidated net revenue of $325 million to $335 million and adjusted EPS of $0.65 to $0.75, and the prior-year comparison was driven by a $147.3 million CH-53K loss reserve adjustment.
- Q3 2026 net revenue $349.5 million, up 34% from $261.4 million in Q3 2025
- Q3 2026 diluted EPS $1.46 versus a loss of $(3.37) in Q3 2025; adjusted diluted EPS $1.68
- Q4 2026 outlook: consolidated net revenue $325 million to $335 million; adjusted EPS $0.65 to $0.75; effective tax rate 29.5% versus prior estimate of 31.5%
- Webcast to discuss results at 9:00 a.m. Eastern Time on October 29, 2026
Read the filing on SEC.gov ↗
Sep 1, 4:37 PM ET
Albany International said it completed its strategic review of the Amelia Earhart Drive facility in Salt Lake City and will keep the site, following an amended CH-53K contract with Sikorsky and new business wins. The company also reversed part of a forward loss reserve from the third quarter of 2025 and raised its third-quarter 2026 adjusted EPS outlook to $1.40 to $1.50, while its net revenue outlook was unchanged.
- The company will retain the Amelia Earhart Drive facility and end the strategic review; Guggenheim Securities served as its financial advisor.
- It reversed a portion of the forward loss reserve recognized in Q3 2025 on the CH-53K contract, and the contract modification is expected to generate positive cash flow beginning in 2027.
- Q3 2026 adjusted EPS outlook rose from $0.60 to $0.70 to $1.40 to $1.50; Q3 consolidated net revenue outlook remains $320 million to $330 million.
- Q4 2026 outlook calls for consolidated net revenue of $325 million to $335 million and adjusted EPS of $0.65 to $0.75; investor webcast on September 2, 2026 at 8:30 a.m. ET.
Read the filing on SEC.gov ↗
Aug 31, 9:05 AM ET
Albany International's Chief Financial Officer, Willard Station, began a medical leave of absence effective August 31, 2026, with no end date set. The board named Controller and Chief Accounting Officer Sean Valashinas acting principal financial officer in addition to his current role, and the filing states there are no changes to his compensation.
- Willard Station, CFO and principal financial officer, began medical leave effective August 31, 2026; duration not determined
- Sean Valashinas, age 55, appointed acting principal financial officer effective August 31, 2026
- Valashinas has been Controller and Chief Accounting Officer since June 9, 2025; no compensation changes disclosed
- Company issued a press release on August 31, 2026 announcing the leave and appointment (Exhibit 99.1)
Read the filing on SEC.gov ↗
Aug 4, 7:31 AM ET
Albany International reported second-quarter 2026 net revenue of $329.5 million, up 6% from $311.4 million a year earlier, and net income attributable to the Company of $17.4 million, or $0.61 per diluted share, compared with $9.2 million, or $0.31, in Q2 2025. The company also gave a third-quarter 2026 outlook calling for consolidated net revenue of $320 million to $330 million and adjusted EPS of $0.60 to $0.70.
- Net revenue was $329.5 million, up 6% from $311.4 million; Engineered Composites revenue rose 14.2% after currency adjustment, while Machine Clothing fell 2.4%.
- Net income attributable to the Company was $17.4 million, or $0.61 per diluted share, versus $9.2 million, or $0.31, in Q2 2025.
- Adjusted EBITDA was $57.8 million, up 11.5%, and adjusted EPS was $0.82 versus $0.57 a year earlier.
- Q3 2026 outlook: consolidated net revenue of $320 million to $330 million and adjusted EPS of $0.60 to $0.70.
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.